Literature DB >> 34607368

Impact of Dietary Sodium Reduction on the Development of Obesity and Type 2 Diabetes in db/db Mice.

Anja Hofmann1,2, Coy Brunssen1, Mirko Peitzsch3, Jennifer Mittag1, Annika Frenzel1, Graeme Eisenhofer3,4, Nicholas F Brown5, Steven M Weldon5, Christian Reeps2, Stefan R Bornstein4,6, Henning Morawietz1.   

Abstract

The impact of dietary sodium reduction on mouse models of type 2 diabetes is not well understood. Therefore, we analyzed the effect of a low-salt diet on obesity and parameters of type 2 diabetes in db/db mice. Five-week-old male db/db and lean db/m mice were fed a normal salt (0.19% Na+, NS) or a low-salt diet (<0.03% Na+, LS) for 5 weeks. Body and organ weight and parameters of glucose and insulin tolerance were analyzed. Plasma levels of steroids were determined by liquid chromatography tandem mass spectrometry. Body weight, glucose, and insulin tolerance were not affected by LS. The amount of gonadal adipose tissue showed a trend to be increased by LS whereas liver, pancreas, kidney, heart, and adrenal weight remained unaffected. LS reduced urinary sodium-to-creatinine ratio but did not affect plasma Na+ levels in both genotypes. Plasma and urinary potassium-to-creatinine ratio did not differ in all groups of mice. Aldosterone as a major determinant of changes in dietary sodium remained unaffected by LS in db/db mice as well as further investigated steroid hormones. The present study showed reduced sodium-to-creatinine ratio, but no additional effects of dietary sodium reduction on major metabolic parameters and steroid levels in obese and hyper-glycemic db/db mice. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34607368     DOI: 10.1055/a-1625-6296

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  1 in total

1.  Emotion Recognition Algorithm Application Financial Development and Economic Growth Status and Development Trend.

Authors:  Dahai Wang; Bing Li; Xuebo Yan
Journal:  Front Psychol       Date:  2022-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.